Ireland· IE-PA-PA0711/299/001

Ticagrelor Rowex 90 mg Film-coated tablets

A ticagrelor product containing ticagrelor, registered in Ireland by Rowex Limited,. The same ATC class is registered in 18 of our 19 countries.

ATC B01AC24

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ticagrelorAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ticagrelor is registered in 18 of 19 countries.

Countries holding a registration under ATC B01AC24 (ticagrelor), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
10 of them publish a price we can compare per daily dose

Search ticagrelor products by name

Ticagrelor · ATC B01AC24

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ticagrelor costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), the median price runs from $0.68 in United States to $1.97 in Spain — a ×2.9 gap.

5 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Ticagrelor · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

ES Spain$1.97
CH Switzerland$1.80
IT Italy$0.94
FR France$0.77
US United States$0.68 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Ticagrelor
Manufacturer: Rowex Limited,
Country: Ireland (IE)
ATC code: B01AC24
ATC class: Ticagrelor
Defined daily dose: 0.18 g, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA0711/299/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

529 interactions on record for ticagrelor.

Graded by severity as the source publishes them — 76 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ticagrelor against other medicines How interaction checks work

Ticagrelor · interactions on record

529 records

76 severe
354 moderate
60 minor

Most severe, free to view

LonafarnibA16AX20severe
DalteparinB01AB04severe
EnoxaparinB01AB05severe
DanaparoidB01AB09severe

39 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ticagrelor in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticagrelor products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Ticagrelor, Ticagrelor Accord
Belgium · Ticagrelor Ab, Ticagrelor Eg
Bulgaria · ?????????? Accord, Tilobrastil
Cyprus · Brirem, Lacrat
Czechia · Atirabo, Atixarso
Germany · Ticabril, Ticagrelor
Denmark · Lacrat, Ticagrelor Accord
Estonia · Agtileq, Atirabo
Spain · Lacrat, Ticagrelor Abdi
Finland · Ticagrelor Accord, Ticagrelor Avansor
France · Ticagrelor Accord, Ticagrelor Arrow
United Kingdom (Northern Ireland) · Bellaflow, Clariflow
Greece · Agilinta, Atixarso
Croatia · Atixarso, Greccas
Hungary · Atirabo, Atixarso
Iceland · Brilique, Ticagrelor Krka
Italy · Auretica, Ticagrelor
Liechtenstein · Brilique
Lithuania · Atirabo, Atixarso
Luxembourg · Ticagelor Eg (Eurogenerics) Nv, Ticagrelor Eg
Latvia · Atirabo, Atixarso
Malta · Brirem, Croalcril
Netherlands · Ticagrelor Abdi, Ticagrelor Accord
Norway · Brilique, Ticagrelor Accord
Poland · Atirabo, Atixarso
Portugal · Brirem, Lacrat Mg
Romania · Atixarso, Croalcril
Sweden · Auretica, Ecugra
Slovenia · Atixarso, Lacrat
Slovakia · Atirabo, Atixarso

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b89022f9-673d-467f-af99-22834785d199
GET /v1/drugs/b89022f9-673d-467f-af99-22834785d199?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "B01AC24"
  ],
  "strength": null,
  "pa_number": "PA0711/299/001",
  "substances": [
    "Ticagrelor"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "05/03/2021",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0193-166-003"
}

API reference MCP server Plans

See everything about ticagrelor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console